Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Jane Lowe Meisel
When the personal becomes political: The impact of the Dobbs decision on women with cancer
Abstract Approximately 6400 pregnant women are diagnosed with cancer in the United States each year, and the recent decision by the Supreme Court to overturn the constitutional right to abortion will prevent many of these women from making critical decisions about their medical treatment. In many cases, lack of access to safe first-trimester abortions may compromise these patients' cancer outcomes significantly, reducing their chances of living long enough to raise their child in the first place.
Trastuzumab deruxtecan extends survival in HER2-low metastatic breast cancer
Source/Disclosures Source: Modi S, et al. Abstract LBA3. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago. Disclosures: AstraZeneca and Daiichi Sankyo supported the study. Modi reports no relevant financial disclosures. Please see the abstract for all other researchers’ relevant financial disclosures. We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Sacituzumab govitecan significantly extends PFS in advanced breast cancer subset
Source/Disclosures Source: Rugo HS, et al. Abstract LBA1001. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago. Disclosures: Rugo reports honoraria from Mylan, Puma Biotechnology and Samsung Bioepis; consultant/advisory roles with Napo Pharmaceuticals; and research funding from Astellas Pharma, AstraZeneca, Ayala Pharmaceuticals, Daiichi Sankyo, Genentech, Gilead Sciences, Lilly, Merck, Novartis, OBI Pharma, Odonate Therapeutics, Pfizer and Sermonix Pharmaceuticals.
We have to talk about it: Bringing fertility into the conversation for young women with breast cancer
Editorial Jane Lowe Meisel MD Corresponding Author jane.l.meisel@emory.edu orcid.org/0000-0002-2642-865X Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia Corresponding Author: Jane Lowe Meisel, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 1365 Clifton Rd NE, Atlanta, GA 30322 (jane.l.meisel@emory.edu).
Weighing the influence of race and obesity on outcomes in patients with early‐stage breast cancer
Editorial Jane Lowe Meisel MD Corresponding Author jane.l.meisel@emory.edu orcid.org/0000-0002-2642-865X Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia Corresponding Author: Jane Lowe Meisel, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Rd, C Building, Atlanta, GA 30322‐1013 (jane.l.meisel@emory.edu).
Winship members present important findings at ASCO 2017
More than 20 Winship members will present their research in oral platform or poster sessions at the 2017 annual meeting of the American Society of Clinical Oncology (ASCO) June 2- 6 in Chicago.
Emotional Vulnerability: Risk and Reward
By Jane Lowe Meisel, MD As an oncologist who treats exclusively breast and gynecologic malignancies, I have a heavily female patient population, and given that I practice at a large academic center in a city with a young population, many of my patients are within a few years of my age.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jane Lowe
Contact Jane Lowe, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack